16 min
How to improve your clinic organisation to ensure a better patient experience, and optimise adherence to treatment A Chat with Anat
-
- Life Sciences
Today my guest is Mr James Talks, Consultant Ophthalmologist at the Newcastle Eye Centre in Newcastle, UK. He joins me to discuss how clinic organisation can impact adherence and persistence and what aspects we can modify to ensure a better patient experience and optimise adherence to treatment.
This is not intended for UK audiences.
Speaker disclosures:
Professor Anat Loewenstein
Consultancy, Research grants: Allergan, Bayer, Beyeonics Surgical, KHB, Novartis, Notal Vision, Oculis, Oxurion, Pres-By, Roche, Sensor, WebMD, Xbrane
Mr James Talks
Consultancy, Research grants: Allergan, Bayer, Boehringer Ingelheim, Novartis, Roche
This podcast is not intended for UK audiences.
This podcast series is produced and funded by Bayer. The views and opinions expressed throughout this podcast are the speakers' own, based on their clinical experience and expertise.
The Barometer Program is managed by clinical leaders in ophthalmology as well as representatives from the IFA, IAPB and Bayer. The activities of the Barometer Program are funded and facilitated by Bayer where the scientists and representatives from IFA and IAPB retain decision authority to the research scope, methods, analysis of findings, and dissemination of the outputs of the Barometer Program.
The Vision Academy is a group of over 100 international experts who, through their collective expertise, provide consensus guidance for managing clinically challenging situations, especially in areas of controversy or with insufficient conclusive evidence. The Vision Academy is funded and facilitated by Bayer. The opinions and guidance of the Vision Academy outputs are those of its members and do not necessarily reflect the opinions of Bayer.
Today my guest is Mr James Talks, Consultant Ophthalmologist at the Newcastle Eye Centre in Newcastle, UK. He joins me to discuss how clinic organisation can impact adherence and persistence and what aspects we can modify to ensure a better patient experience and optimise adherence to treatment.
This is not intended for UK audiences.
Speaker disclosures:
Professor Anat Loewenstein
Consultancy, Research grants: Allergan, Bayer, Beyeonics Surgical, KHB, Novartis, Notal Vision, Oculis, Oxurion, Pres-By, Roche, Sensor, WebMD, Xbrane
Mr James Talks
Consultancy, Research grants: Allergan, Bayer, Boehringer Ingelheim, Novartis, Roche
This podcast is not intended for UK audiences.
This podcast series is produced and funded by Bayer. The views and opinions expressed throughout this podcast are the speakers' own, based on their clinical experience and expertise.
The Barometer Program is managed by clinical leaders in ophthalmology as well as representatives from the IFA, IAPB and Bayer. The activities of the Barometer Program are funded and facilitated by Bayer where the scientists and representatives from IFA and IAPB retain decision authority to the research scope, methods, analysis of findings, and dissemination of the outputs of the Barometer Program.
The Vision Academy is a group of over 100 international experts who, through their collective expertise, provide consensus guidance for managing clinically challenging situations, especially in areas of controversy or with insufficient conclusive evidence. The Vision Academy is funded and facilitated by Bayer. The opinions and guidance of the Vision Academy outputs are those of its members and do not necessarily reflect the opinions of Bayer.
16 min